Capital World Investors Acadia Pharmaceuticals Inc Transaction History

Capital World Investors

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$13.03 - $21.81 $13.8 Million - $23.1 Million	-1,057,000 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$15.07 - $22.34 $61.4 Million - $91.1 Million	-4,076,000 Reduced 79.41%	1,057,000 $16.1 Million
Q1 2018 May 15, 2018	BUY	$22.47 - $32.33 $51.8 Million - $74.5 Million	2,305,000 Added 81.51%	5,133,000 $115 Million
Q4 2017 Feb 14, 2018	BUY	$26.84 - $39.14 $7.38 Million - $10.8 Million	275,000 Added 10.77%	2,828,000 $85.2 Million
Q3 2017 Nov 14, 2017	BUY	$29.49 - $38.37 $75.3 Million - $98 Million	2,553,000	2,553,000 $96.2 Million

279

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.76B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Capital World Investors, based on Form 13F filings with the SEC.

Stay updated on Capital World Investors with notifications on news.